Suzuken Acquires medimo, Developer of Medical Document Creation System – Kotora

The news of Suzuken making medimo, a developer of medical document creation systems, a subsidiary suggests a new phase in promoting DX within the healthcare industry.The fact that a major pharmaceutical wholesaler is going beyond mere logistics and information provision to delve into the efficiency of document creation, a core operation for medical institutions, is evidence of the expanding scope of support for medical institution management.

In the context of medical M&A and business succession, this move holdsthe potential to bring about significant changes in the evaluation criteria for medical institutions.For executives facing succession issues, not only patient numbers and facilities but also"how efficiently operations are managed in a digitized environment"can become factors that influence the valuation of the acquiring entity and, consequently, the success of business succession. The adoption of systems like medimo can be seen not just as a reduction in daily operational burden, but as a strategic investment to enhance future business value, particularly appealing to younger successors who are tech-savvy or corporations seeking to strengthen regional partnerships.

Executives of medical institutions should recognize that promoting DX in their own facilities is not merely a cost, but"an investment" with future business succession in mind.Efficient system implementation will enhance operational transparency, facilitate the handover process, and ultimately result in a more attractive M&A deal.Before considering closure, it is essential to explore the potential for value enhancement through digitalization and subsequent succession.